91 related articles for article (PubMed ID: 11975321)
1. [Breast cancer in women with trisomy 21].
Satgé D; Sasco AJ; Pujol H; Rethoré MO
Bull Acad Natl Med; 2001; 185(7):1239-52; discussion 1252-4. PubMed ID: 11975321
[TBL] [Abstract][Full Text] [Related]
2. A lower risk of dying from urological cancer in Down syndrome: clue for cancer protecting genes on chromosome 21.
Satgé D; Sasco AJ; Day S; Culine S
Urol Int; 2009; 82(3):296-300. PubMed ID: 19440017
[TBL] [Abstract][Full Text] [Related]
3. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome: case-control study.
Czeizel AE; Puhó E
Nutrition; 2005 Jun; 21(6):698-704; discussion 774. PubMed ID: 15925294
[TBL] [Abstract][Full Text] [Related]
4. Consanguinity, non-disjunction, parental age and Down's syndrome.
Sayee R; Thomas IM
J Indian Med Assoc; 1998 Nov; 96(11):335-7. PubMed ID: 10218319
[TBL] [Abstract][Full Text] [Related]
5. Cancers and immune related diseases associated with Down's syndrome: a record linkage study.
Goldacre MJ; Wotton CJ; Seagroatt V; Yeates D
Arch Dis Child; 2004 Nov; 89(11):1014-7. PubMed ID: 15499053
[TBL] [Abstract][Full Text] [Related]
6. Pattern of malignant disorders in individuals with Down's syndrome.
Hasle H
Lancet Oncol; 2001 Jul; 2(7):429-36. PubMed ID: 11905737
[TBL] [Abstract][Full Text] [Related]
7. [Time trends, estimates and projects for breast cancer incidence and mortality in China].
Yang L; Li LD; Chen YD; Parkin DM
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):438-40. PubMed ID: 17152490
[TBL] [Abstract][Full Text] [Related]
8. Risks of leukaemia and solid tumours in individuals with Down's syndrome.
Hasle H; Clemmensen IH; Mikkelsen M
Lancet; 2000 Jan; 355(9199):165-9. PubMed ID: 10675114
[TBL] [Abstract][Full Text] [Related]
9. Better surgical prognosis for patients with complete atrioventricular septal defect and Down's syndrome.
Formigari R; Di Donato RM; Gargiulo G; Di Carlo D; Feltri C; Picchio FM; Marino B
Ann Thorac Surg; 2004 Aug; 78(2):666-72; discussion 672. PubMed ID: 15276542
[TBL] [Abstract][Full Text] [Related]
10. Increased superoxide dismutase and Down's syndrome.
Turrens JF
Med Hypotheses; 2001 Jun; 56(6):617-9. PubMed ID: 11399108
[TBL] [Abstract][Full Text] [Related]
11. Cancer incidence and mortality in France over the period 1978-2000.
Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
[TBL] [Abstract][Full Text] [Related]
12. [The aging of Down's Syndrome subjects].
Fromage B; Anglade P
Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
[TBL] [Abstract][Full Text] [Related]
13. Down's syndrome as a model disease.
Scoggin CH; Patterson D
Arch Intern Med; 1982 Mar; 142(3):462-4. PubMed ID: 6461305
[TBL] [Abstract][Full Text] [Related]
14. [Study on the use of model life tables methodology in birth defect's life expectancy estimation: the case of Down's syndrome].
Ji Y; Chen G; Zheng XY
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Apr; 29(4):396-400. PubMed ID: 18844002
[TBL] [Abstract][Full Text] [Related]
15. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
[TBL] [Abstract][Full Text] [Related]
16. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
[TBL] [Abstract][Full Text] [Related]
17. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.
Bensing S; Brandt L; Tabaroj F; Sjöberg O; Nilsson B; Ekbom A; Blomqvist P; Kämpe O
Clin Endocrinol (Oxf); 2008 Nov; 69(5):697-704. PubMed ID: 18727712
[TBL] [Abstract][Full Text] [Related]
18. A lack of neuroblastoma in Down syndrome: a study from 11 European countries.
Satgé D; Sasco AJ; Carlsen NL; Stiller CA; Rubie H; Hero B; de Bernardi B; de Kraker J; Coze C; Kogner P; Langmark F; Hakvoort-Cammel FG; Beck D; von der Weid N; Parkes S; Hartmann O; Lippens RJ; Kamps WA; Sommelet D
Cancer Res; 1998 Feb; 58(3):448-52. PubMed ID: 9458088
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte glycohydrolases in subjects with trisomy 21: could Down's syndrome be a model of accelerated ageing?
Massaccesi L; Corsi MM; Baquero-Herrera CJ; Licastro F; Tringali C; Venerando B; Lombardo A; Alberghino A; Goi G
Mech Ageing Dev; 2006 Apr; 127(4):324-31. PubMed ID: 16460783
[TBL] [Abstract][Full Text] [Related]
20. The effect of service screening on breast cancer mortality rates.
Cox B
Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
